As a drug development consultant, William G. Kramer, Ph.D., draws on his over 40 years of experience in the pharmaceutical industry and academic research to work with client companies in the development of research strategies to minimize the time for completion of clinical trials and FDA approval. An expert in clinical pharmacology, pharmacokinetics and pharmacodynamics, Dr. Kramer assists client companies in program design, protocol preparation, study implementation, and the analysis and interpretation of results. Dr. Kramer has prepared pharmacokinetic sections of INDs, NDAs, ANDAs, BLAs, and submissions to European regulatory agencies.  He has presented at all levels of FDA meetings, including Advisory Committee Meetings, and has published extensively on the pharmacokinetics/dynamics of drugs in adult and pediatric populations. 

Prior to forming Kramer Consulting LLC, Dr. Kramer was a Senior Consultant at Quintiles Consulting and before that served as Director, Clinical Research, and Head, Pharmacokinetics and Bioanalytics, at Boehringer Mannheim where he created and maintained the pharmacokinetic plan for all drug projects in the U.S. Other positions in which Dr. Kramer worked include serving in the Department of Drug Metabolism and Pharmacokinetics at Schering-Plough Corporation, and he spent ten years teaching and conducting clinical pharmacokinetic research at the University of Houston College of Pharmacy.

Dr. Kramer received a Ph.D. in Pharmaceutics at Ohio State University, Columbus, OH, and a B.S. in Pharmacy from the University of Pittsburgh, PA.